Publications dans lesquelles il/elle collabore avec MIGUEL ANGEL SERRA DESFILIS (12)

2024

  1. Development and validation of an image biomarker to identify metabolic dysfunction associated steatohepatitis: MR–MASH score

    Liver International, Vol. 44, Núm. 1, pp. 202-213

2023

  1. Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 8, pp. 594-602

2022

  1. Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease

    Radiology, Vol. 302, Núm. 2, pp. 345-354

  2. Metabolic syndrome is associated with poor response to rifaximin in minimal hepatic encephalopathy

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. Digital pathology enables automated and quantitative assessment of inflammatory activity in patients with chronic liver disease

    Biomolecules, Vol. 11, Núm. 12

  2. Digital pathology: accurate technique for quantitative assessment of histological features in metabolic-associated fatty liver disease

    Alimentary Pharmacology and Therapeutics, Vol. 53, Núm. 1, pp. 160-171

2018

  1. Cirrhotic patients with minimal hepatic encephalopathy have increased capacity to eliminate superoxide and peroxynitrite in lymphocytes, associated with cognitive impairment

    Free Radical Research, Vol. 52, Núm. 1, pp. 118-133

  2. Learning and Memory Impairments in Patients with Minimal Hepatic Encephalopathy are Associated with Structural and Functional Connectivity Alterations in Hippocampus

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. Minimal hepatic encephalopathy is associated with expansion and activation of CD4+CD28-, Th22 and Tfh and B lymphocytes

    Scientific Reports, Vol. 7, Núm. 1

  2. Reduced resting state connectivity and gray matter volume correlate with cognitive impairment in minimal hepatic encephalopathy

    PLoS ONE, Vol. 12, Núm. 10

  3. The PHES battery does not detect all cirrhotic patients with early neurological deficits, which are different in different patients

    PLoS ONE, Vol. 12, Núm. 2

2015

  1. Is Cognitive Impairment in Cirrhotic Patients Due to Increased Peroxynitrite and Oxidative Stress?

    Antioxidants and Redox Signaling, Vol. 22, Núm. 10, pp. 871-877